固德威：拟1亿–1.5亿元回购公司股份 6月13日晚，固德威（688390）发布公告称，公司计划以集中竞价方式回购股份，回购资金总额在1亿元 至1.5亿元之间，回购价格上限为53元/股，预计回购股份数量为189万股至283万股，占总股本的0.78% 至1.17%。 资料显示，固德威成立于2010年11月，主营业务是太阳能、储能等新能源电力电源设备的研发、生产和 销售，并致力于为家庭、工商业用户及地面电站提供智慧能源管理等整体解决方案。 所属行业：电力设备–光伏设备–逆变器 双良节能：中标甘肃能化庆阳2×660MW煤电项目 6月13日晚，双良节能（600481）发布公告称，公司和中建研科技股份有限公司、河南省第二建设集团 有限公司中标甘肃能化庆阳2×660MW煤电项目工程间冷塔EPC工程招标项目，预计中标总额为2.37亿 元，占公司2024年度营业收入的1.82%。 资料显示，双良节能成立于1995年10月，主营业务是节能节水系统业务及新能源系统业务。 所属行业：电力设备–光伏设备–硅料硅片 中国太保：前5月两子公司保费收入合计2271.69亿元 6月13日晚，中国太保（601601）发布公告称，1至5月，公司 ...

证券研究报告 2025 年 06 月 13 日 | 市场数据 | | | | --- | --- | --- | | 指数名称 | 收盘 | 涨跌% | | 上证指数 | 3402.66 | 0.01 | | 深证成指 | 10234.33 | -0.11 | | 创业板指 | 2067.15 | 0.26 | | 科创 50 | 977.97 | -0.30 | | 北证 50 | 1424.38 | -0.25 | | 沪深 300 | 3892.20 | -0.06 | A 股市场概览 | 类别 | 总市值 | 流通市 | 市盈率 | 市净率 | | --- | --- | --- | --- | --- | | | (亿元) | 值(亿元) | PE | PB | | 上证指数 | 654713 | 512111 | 12.07 | 1.25 | | 深证成指 | 226271 | 184517 | 20.06 | 2.12 | | 创业板指 | 58408 | 46189 | 27.19 | 3.78 | | 科创 50 | 33774 | 22095 | 52.83 | 4.07 | | 北证 5 ...

Policy Developments - The National Health Commission of China is taking measures to ensure blood supply in key areas and important time periods due to a noticeable decline in voluntary blood donations, influenced by factors such as aging population and lifestyle changes [2] - In 2024, the total blood supply in China is expected to decrease year-on-year, with a cumulative blood allocation of 3.613 million units, including 583,000 units allocated between provinces, representing a 35.1% increase [2] Drug and Medical Device Approvals - Kelun Pharmaceutical announced that its subsidiary has received drug registration approval for "Cefazolin Sodium/ Sodium Chloride Injection," which is packaged in a dual-chamber bag and is suitable for emergency treatment [4] - *ST Sailong's subsidiary has obtained a drug registration certificate for Famotidine Injection, classified as a Category A drug under the national medical insurance list, primarily used for treating upper gastrointestinal bleeding [5] Capital Market Activities - Borui Pharmaceutical plans to invest 20 million yuan to subscribe to the increased registered capital of Geek Gene Technology, acquiring a 4.1667% stake in the company [7] Industry Developments - Eli Lilly announced the launch of the multi-dose prefilled pen for Tirzepatide Injection in China, aimed at addressing the needs of the growing number of diabetes and obesity patients [9] - The adult overweight rate in China is 34.3%, with an obesity rate of 16.4%, highlighting the increasing demand for weight management treatments [9] - In the first quarter of this year, Tirzepatide contributed $6.15 billion in revenue to Eli Lilly, accounting for approximately 48% of the company's total revenue [10] - Hanyu Pharmaceutical has completed the enrollment of all subjects for the Phase III clinical trial of Semaglutide Injection for weight management, currently in the follow-up phase [11] Shareholder Actions - Nine Strong Bio's major shareholder completed a share reduction plan, reducing their holdings from 30,969,636 shares to 30,769,636 shares, a decrease from 5.30% to 5.26% of voting shares [13] - Yifeng Pharmacy's controlling shareholder plans to reduce their stake by up to 2%, amounting to no more than 24,248,336 shares [14]

科伦药业（002422）公告，子公司湖南科伦制药有限公司的化学药品"注射用头孢唑林钠/氯化钠注射 液"于近日获得国家药品监督管理局的药品注册批准。该药品为粉液双室袋包装，按头孢唑林计1.0g， 氯化钠注射液100ml：0.9g。粉液双室袋可避免配制过程中的错配和污染风险，适用于紧急状态下的快 速救治。头孢唑林钠是抗感染治疗的经典用药，2024年注射剂中国销售13.5亿元。科伦药业为国内第2 家获批粉液双室袋包装形式的公司。 ...